Neurontin Whistleblower Alleges Sham Research Arrangements, Atty. Says

The whistleblower suit against Parke-Davis includes allegations that the company ran sham research programs to encourage use of its products, Sidley Austin Brown & Wood partner Scott Bass told a recent Drug Information Association meeting on marketing and compliance in New York City